Early-onset Alzheimer disease (EOAD), which presents in patients younger than 65 years,
has frequently been described as having different features from those of late-onset …

To develop a new method for measuring Alzheimer's disease (AD)-specific similarity of
cortical atrophy patterns at the individual-level, we employed an individual-level machine …

Age is not only the greatest risk factor for Alzheimer's disease (AD) but also a key modifier of
disease presentation and progression. Here, we investigate how longitudinal atrophy …

Background: The aim of this study was to investigate the frequency and severity of
neuropsychiatric symptoms (NPS) in patients with early onset Alzheimer's disease (EAOD) …

Health-care professionals, patients, and families seek as much information as possible
about prognosis for patients with Alzheimer's disease (AD); however, we do not yet have a …

Introduction Previous research on structural changes in early‐onset Alzheimer's disease
(EOAD) and late‐onset Alzheimer's disease (LOAD) have reported inconsistent findings …

La enfermedad de Alzheimer de inicio precoz (EAIP), definida como la que se manifiesta
antes de los 65 años de edad, muestra ciertas características diferentes de la enfermedad …

We evaluated how the impact of apolipoprotein E4 (APOE4) differs according to age in
Alzheimer's disease (AD) patients. We recruited 846 AD patients and 815 cognitively normal …

Background: Sex effects on the progression of Alzheimer's disease (AD) have received less
attention than other demographic factors, including onset age and education. Objective: The …

La maladie d'Alzheimer (AD) est la principale cause de démence neurodégénérative,
caractérisée à 95% par des formes tardives (LOAD) qui présentent des troubles mnésiques …